Urology News Feeds
Occurrence of and Risk Factors for Urological Intervention during Benign Hysterectomy – Analysis of the National Surgical Quality Improvement Program Database
Antegrade Sclerotherapy to Treat All Types of Varicoceles in the Paediatric Population: Experience of a Single Centre.
Temporal Trends in Conduit Urinary Diversion with Concomitant Cystectomy for Benign Indications: a Population-Based Analysis
Re: Update on Lasers in Urology. Current Assessment on Holmium:yttrium-aluminum-garnet (Ho:YAG) Laser Lithotripter Settings and Laser Fibers
Department of Urology, SLK Kliniken Heilbronn, Heilbronn, Germany
Corresponding author. Department of Urology, SLK Kliniken Heilbronn, Am Gesundbrunnen 20–24, 74076 Heilbronn, Germany.
© 2016 Published by Elsevier B.V.
Bladder cancer has become a common cancer globally, with an estimated 430 000 new cases diagnosed in 2012.Objective
We examine the most recent global bladder cancer incidence and mortality patterns and trends, the current understanding of the aetiology of the disease, and specific issues that may influence the registration and reporting of bladder cancer.Evidence acquisition
Global bladder cancer incidence and mortality statistics are based on data from the International Agency for Research on Cancer and the World Health Organisation (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organisation Mortality).Evidence synthesis
Bladder cancer ranks as the ninth most frequently-diagnosed cancer worldwide, with the highest incidence rates observed in men in Southern and Western Europe, North America, as well in certain countries in Northern Africa or Western Asia. Incidence rates are consistently lower in women than men, although sex differences varied greatly between countries. Diverging incidence trends were also observed by sex in many countries, with stabilising or declining rates in men but some increasing trends seen for women. Bladder cancer ranks 13th in terms of deaths ranks, with mortality rates decreasing particularly in the most developed countries; the exceptions are countries undergoing rapid economic transition, including in Central and South America, some central, southern, and eastern European countries, and the Baltic countries.Conclusions
The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking, although infection with Schistosoma haematobium and other risk factors are major causes in selected populations. Differences in coding and registration practices need to be considered when comparing bladder cancer statistics geographically or over time.Patient summary
The main risk factor for bladder cancer is tobacco smoking. The observed patterns and trends of bladder cancer incidence worldwide appear to reflect the prevalence of tobacco smoking.Take Home Message
Diverging patterns in bladder cancer are observed linked to the phase of the tobacco epidemic, and in specific countries, the prevalence of Schistosoma haematobium infection. While other factors contribute, harmonisation of registry coding of noninvasive tumours will improve international comparability.
Keywords: Bladder, Cancer, Statistics, Incidence, Mortality.Footnotes
a Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
b Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA
Corresponding author. Section of Cancer Surveillance, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France. Tel. +33 4 72 73 84 53; Fax: +33 4 72 73 86 96.
© 2016 European Association of Urology, Published by Elsevier B.V.
Re: Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection Through Improved Risk Stratification
Department of Urology, Acıbadem University Kadıköy Hospital, Istanbul, Turkey
Corresponding author. Department of Urology, Acıbadem University Kadıköy Hospital, Kadıköy, Istanbul, 34660, Turkey.
© 2016 Published by Elsevier B.V.